|
1.8
|
https://www.ema.europa.eu/en/medicines/human/EPAR/lynkuet
|
N/A
|
1
|
|
1.8
|
https://www.ema.europa.eu/en/medicines/human/EPAR/tryngolza
|
N/A
|
1
|
|
1.8
|
https://www.ema.europa.eu/en/news/ixchiq-temporary-restriction-vaccinating-people-65-years-older-be-lifted
|
N/A
|
1
|
|
1.8
|
https://www.ema.europa.eu/en/news/first-treatment-against-liver-scarring-caused-type-fatty-liver-disease
|
N/A
|
1
|
|
1.8
|
https://www.ema.europa.eu/en/news/prac-starts-safety-review-levamisole-medicine-used-treat-parasitic-worm-infections
|
N/A
|
1
|
|
1.8
|
https://www.ema.europa.eu/en/medicines/human/EPAR/eyluxvi
|
N/A
|
1
|
|
1.8
|
https://www.ema.europa.eu/en/medicines/human/EPAR/imaavy
|
N/A
|
1
|
|
1.8
|
https://www.ema.europa.eu/en/medicines/human/EPAR/usrenty
|
N/A
|
1
|
|
1.8
|
https://www.ema.europa.eu/en/medicines/veterinary/EPAR/portela
|
N/A
|
1
|
|
1.8
|
https://www.ema.europa.eu/en/medicines/human/EPAR/zurzuvae
|
N/A
|
1
|
|
1.8
|
https://www.ema.europa.eu/en/news/etf-recommends-updating-covid-19-vaccines-target-new-lp81-variant
|
N/A
|
1
|
|
1.8
|
https://www.ema.europa.eu/en/medicines/human/EPAR/usgena
|
N/A
|
1
|
|
1.8
|
https://www.ema.europa.eu/en/medicines/human/EPAR/eiyzey
|
N/A
|
1
|
|
1.8
|
https://www.ema.europa.eu/en/news/use-paracetamol-during-pregnancy-unchanged-eu
|
N/A
|
1
|
|
1.8
|
https://www.ema.europa.eu/en/medicines/human/EPAR/bildyos
|
N/A
|
1
|
|
1.8
|
https://www.ema.europa.eu/en/medicines/human/EPAR/xbonzy
|
N/A
|
1
|
|
1.8
|
https://www.ema.europa.eu/en/medicines/human/EPAR/acvybra
|
N/A
|
1
|
|
1.8
|
https://www.ema.europa.eu/en/medicines/human/EPAR/ponlimsi
|
N/A
|
1
|
|
1.8
|
https://www.ema.europa.eu/en/medicines/human/EPAR/zvogra
|
N/A
|
1
|
|
1.8
|
https://www.ema.europa.eu/en/documents/other/pandemrix-package-leaflet_en.pdf
|
N/A
|
1
|
|
1.8
|
https://www.ema.europa.eu/en/medicines/human/EPAR/kyinsu
|
N/A
|
1
|
|
1.8
|
https://www.ema.europa.eu/en/news/ema-starts-review-ixchiq-live-attenuated-chikungunya-vaccine
|
N/A
|
1
|
|
1.8
|
https://www.ema.europa.eu/en/medicines/human/EPAR/kefdensis
|
N/A
|
1
|
|
1.8
|
https://www.ema.europa.eu/en/medicines/human/EPAR/waylivra
|
N/A
|
1
|
|
1.8
|
https://www.ema.europa.eu/en/medicines/human/EPAR/degevma
|
N/A
|
1
|
|
1.8
|
https://www.ema.europa.eu/en/news/first-treatment-recommended-rare-immunoglobulin-related-autoimmune-disease
|
N/A
|
1
|
|
1.8
|
https://www.ema.europa.eu/en/news/new-injection-easier-prevention-hiv-infection-eu-worldwide
|
N/A
|
1
|
|
1.8
|
https://www.ema.europa.eu/en/medicines/human/EPAR/vgenfli
|
N/A
|
1
|
|
1.8
|
https://www.ema.europa.eu/en/medicines/human/EPAR/afiveg
|
N/A
|
1
|
|
1.8
|
https://www.ema.europa.eu/en/medicines/human/EPAR/yeytuo
|
N/A
|
1
|
|
1.8
|
https://www.ema.europa.eu/en/medicines/human/EPAR/gobivaz
|
N/A
|
1
|
|
1.8
|
https://www.ema.europa.eu/en/news/new-stem-cell-therapy-treat-patients-blood-cancers
|
N/A
|
1
|
|
1.8
|
https://www.ema.europa.eu/en/medicines/human/EPAR/enflonsia
|
N/A
|
1
|
|
1.8
|
https://www.ema.europa.eu/en/medicines/human/EPAR/bilprevda
|
N/A
|
1
|
|
1.8
|
https://www.ema.europa.eu/en/medicines/human/EPAR/zemcelpro
|
N/A
|
1
|
|
1.8
|
https://www.ema.europa.eu/en/medicines/human/EPAR/ekterly
|
N/A
|
1
|
|
1.8
|
https://www.ema.europa.eu/en/medicines/human/EPAR/rezdiffra
|
N/A
|
1
|
|
1.8
|
https://www.ema.europa.eu/en/medicines/human/EPAR/mynzepli
|
N/A
|
1
|
|
1.8
|
https://www.ema.europa.eu/en/medicines/human/EPAR/yeytuo#news-on
|
N/A
|
1
|
|
1.8
|
https://www.ema.europa.eu/en/medicines/dhpc/ixchiq-0
|
N/A
|
1
|
|
1.8
|
https://www.ema.europa.eu/en/medicines/human/EPAR/romvimza
|
N/A
|
1
|
|
1.8
|
https://www.ema.europa.eu/en/documents/psusa/alprazolam-list-nationally-authorised-medicinal-products-psusa00000109202203_en.pdf
|
N/A
|
1
|